Skip to main content

Differentiating LBBB-Pattern SVT From VT Using Initial Forces in Lead V1

VT vs SVT on Ecg

Differentiating LBBB-Pattern SVT From VT Using Initial Forces in Lead V1

Based on the classic Kindwall Criteria (Kindwall et al., Circulation 1988)


Distinguishing supraventricular tachycardia (SVT) with left bundle branch block (LBBB) from ventricular tachycardia (VT) is often challenging because both can produce a broad-complex tachycardia with LBBB morphology.

Kindwall and colleagues (1988) published a landmark analysis identifying initial QRS forces in V1 as a powerful discriminator.


This article explains the why and how of these ECG clues.



---


Background: Why V1 Initial Forces Matter


In true LBBB, ventricular activation starts normally in the right ventricle (RV) and then spreads slowly to the left ventricle (LV).

Thus, the initial portion of the QRS reflects rapid septal activation, which remains normal even if the overall QRS is wide.


In contrast, VT originating from the LV produces abnormal early activation, with slow cell-to-cell conduction from the ectopic focus → leading to slurred, delayed, or absent initial forces.


Kindwall et al. exploited this physiology to differentiate SVT with LBBB from VT.



---


Kindwall Criteria (1988): Initial Forces in V1 to Diagnose VT


Kindwall et al. (Circulation, 1988) established three major criteria in lead V1 that strongly favor VT over SVT with LBBB.


All of these examine the first 40 ms of the QRS.



---


1. RS Interval > 60 ms in V1


Measure from QRS onset to the first change of polarity (from R to S).


If > 60 ms → strongly suggests VT.

Rationale: slow initial activation implies myocardial (not His-Purkinje) conduction.




---


2. Initial r Wave > 30 ms in V1


A small initial r should be short and sharp in true LBBB.


If the initial r is broad, slurred, or ≥ 30 ms → favors VT.

Rationale: early activation is slowed by muscle-to-muscle spread.




---


3. Any Notching in the First 40 ms of QRS


Notching, slurring, or an irregular upstroke in the initial 40 ms indicates abnormal initial depolarization.


Presence of notching → consistent with VT.




---


Physiological Logic Behind Kindwall's Criteria


Feature Why It Happens in SVT-LBBB Why It Suggests VT


Fast initial forces Septum and RV activate normally through His-Purkinje Initial activation occurs away from normal system

Sharp r in V1 Normal initial septal activation Delayed, slurred activation from myocardial focus

No early notching His–Purkinje still drives early depolarization Diseased myocardium causes slow, uneven conduction



Thus:

Normal → fast, clean onset.

VT → slow, wide, notched onset.



---


Putting It Together: Practical Interpretation in V1


SVT with LBBB more likely when:


Initial r is thin, sharp, < 30 ms


RS interval < 60 ms


No notching in the initial upstroke


Overall morphology resembles “classical” LBBB pattern


Clinical context: prior LBBB on baseline ECG, young patient without structural heart disease




---


VT more likely when:


Initial r wave in V1 is wide or slurred


Initial notch within 40 ms


RS interval > 60 ms


Dominant initial forces appear slow or broad


Elderly patient, structural heart disease, prior MI



Kindwall found that these criteria were highly specific for VT when any were present.



---


Clinical Utility


These criteria remain useful even today and have influenced modern algorithms (Brugada, Vereckei, ACLS approaches).

They are especially helpful when a tachycardia looks like LBBB but the clinician must decide quickly between adenosine vs amiodarone, or rate-control vs defibrillation pathways.



---


Conclusion


The Kindwall 1988 initial-forces criteria in V1 remain one of the most elegant and physiologically grounded ways to differentiate SVT with LBBB from true VT.

When the initial 40 ms of QRS in V1 is slow, wide, notched, or delayed, VT becomes the overwhelmingly likely diagnosis.


Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.